Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma

Journal of Neurosurgery: Pediatrics

Volumn 14, Issue 2, 2014, Pages 121-128

  Ervey Jumper, Shawn L H ^a   Garton, Hugh J L ^a   Lau, Darryl ^a   Altshuler, David ^a   Quint, Douglas J ^a   Robertson, Patricia L ^a   Muraszko, Karin M ^a   Maher, Cormac O ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CD31; Medulloblastoma; Oncology; Tumor enhancement; VEGF

Indexed keywords

CD31; HPF = HIGH-POWERED FIELD; HPRT = HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MEDULLOBLASTOMA; ONCOLOGY; RT-PCR = REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; TUMOR ENHANCEMENT; VEGF; VEGF = VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGFR = VEGF RECEPTOR;

ADOLESCENT; ADULT; ANTIGENS, CD31; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84905495720     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2014.4.PEDS13244     Document Type: Article

References (38)

1. Bailey P, Cushing H: Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192-224, 1925
2. Becker RL, Becker AD, Sobel DF: Adult medulloblastoma: review of 13 cases with emphasis on MRI. Neuroradiology 37: 104-108, 1995
3. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 438:932-936, 2005
4. Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, et al: Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 47:623-632, 2000 (Pubitemid 32044708)
5. Crawford JR, MacDonald TJ, Packer RJ: Medulloblastoma in childhood: new biological advances. Lancet Neurol 6:1073-1085, 2007 (Pubitemid 350116703)
6. Cuenod CA, Fournier L, Balvay D, Guinebretière JM: Tumor angiogenesis: pathophysiology and implications for contrastenhanced MRI and CT assessment. Abdom Imaging 31:188-193, 2006
7. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, et al: Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677, 1997 (Pubitemid 27385598)
8. Dhall G: Medulloblastoma. J Child Neurol 24:1418-1430, 2009
9. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990
10. Fruehwald-Pallamar J, Puchner SB, Rossi A, Garre ML, Cama A, Koelblinger C, et al: Magnetic resonance imaging spectrum of medulloblastoma. Neuroradiology 53:387-396, 2011
11. Grau SJ, Trillsch F, Herms J, Thon N, Nelson PJ, Tonn JC, et al: Expression of VEGFR3 in glioma endothelium correlates with tumor grade. J Neurooncol 82:141-150, 2007 (Pubitemid 46431856)
12. Grizzi F, Weber C, Di Ieva A: Antiangiogenic strategies in medulloblastoma: reality or mystery. Pediatr Res 63:584-590, 2008 (Pubitemid 351572230)
13. Grotzer MA, Wiewrodt R, Janss AJ, Zhao H, Cnaan A, Sutton LN, et al: High microvessel density in primitive neuroectodermal brain tumors of childhood. Neuropediatrics 32:75-79, 2001 (Pubitemid 32488000)
14. Huber H, Eggert A, Janss AJ, Wiewrodt R, Zhao H, Sutton LN, et al: Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. Eur J Cancer 37: 2064-2072, 2001 (Pubitemid 32938110)
15. LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, et al: Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. Neuro Oncol 15:442-450, 2013
16. MacDonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV, Cheresh DA, et al: Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery 48:151-157, 2001 (Pubitemid 32039837)
17. Maris JM, Courtright J, Houghton PJ, Morton CL, Gorlick R, Kolb EA, et al: Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program. Pediatr Blood Cancer 50:581-587, 2008 (Pubitemid 351155829)
18. Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, et al: Childhood medulloblastoma. Crit Rev Oncol Hematol 79:65-83, 2011
19. Nelson M, Diebler C, Forbes WS: Paediatric medulloblastoma: atypical CT features at presentation in the SIOP II trial. Neuroradiology 33:140-142, 1991
20. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al: Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202-4208, 2006 (Pubitemid 46622300)
21. Poretti A, Meoded A, Huisman TA: Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 35:32-47, 2012
22. Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A: Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 14:971-976, 2008 (Pubitemid 351302541)
23. Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, et al: Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. Clinical article. J Neurosurg 116: 1172-1181, 2012
24. Shibuya M: Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. FEBS J 276:4636-4643, 2009
25. Shibuya M: Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9:225-231, 2006
26. Slongo ML, Molena B, Brunati AM, Frasson M, Gardiman M, Carli M, et al: Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro Oncol 9:384-392, 2007
27. Smee RI, Williams JR, De-Loyde KJ, Meagher NS, Cohn R: Medulloblastoma: progress over time. J Med Imaging Radiat Oncol 56:227-234, 2012
28. Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW: Patterns of contrast enhancement in the brain and meninges. Radiographics 27:525-551, 2007
29. Thompson G, Mills SJ, Coope DJ, O'Connor JP, Jackson A: Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. Br J Radiol 84 Spec No 2: S127-S144, 2011
30. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK: Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731-3736, 2004 (Pubitemid 38697278)
31. Tortori-Donati P, Fondelli MP, Rossi A, Cama A, Caputo L, Andreussi L, et al: Medulloblastoma in children: CT and MRI findings. Neuroradiology 38:352-359, 1996 (Pubitemid 26148048)
32. Tural S, Gercek A, Konya D, Ozgen S, Toplamoglu H, Ozek MM: Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma. J Clin Neurosci 16:1199-1202, 2009
33. Tynninen O, Aronen HJ, Ruhala M, Paetau A, Von Boguslawski K, Salonen O, et al: MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol 34:427-434, 1999 (Pubitemid 29239360)
34. Urberuaga A, Navajas A, Burgos J, Pijoán JI: A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years. Childs Nerv Syst 22: 466-474, 2006
35. Vaquero J, Zurita M, Morales C, Coca S: Prognostic significance of tumor-enhancement and angiogenesis in oligodendroglioma. Acta Neurol Scand 106:19-23, 2002 (Pubitemid 34666573)
36. Wedge SR, Kendrew J, Hennequin LF, Valentine PJ, Barry ST, Brave SR, et al: AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res 65:4389-4400, 2005 (Pubitemid 40775678)
37. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, et al: Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553-563, 2004 (Pubitemid 40017699)
38. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, et al: Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71:6061-6072, 2011